Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath) by epivax3 | Oct 21, 2016
The ISPRI Toolkit Rapidly Screens Biologic Product Candidates for Immunogenic Potential Driven by T cell Epitope Content and Foreignness by epivax3 | Oct 21, 2016
